Cargando…

Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136]

Detalles Bibliográficos
Autores principales:	Ottonelli, Ilaria, Duskey, Jason Thomas, Genovese, Filippo, Pederzoli, Francesca, Caraffi, Riccardo, Valenza, Marta, Tosi, Giovanni, Vandelli, Maria Angela, Ruozi, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314191/ https://www.ncbi.nlm.nih.gov/pubmed/37396626 http://dx.doi.org/10.1016/j.ijpx.2023.100182

Ejemplares similares

Quantitative comparison of the protein corona of nanoparticles with different matrices
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

Tunneling Nanotubes: A New Target for Nanomedicine?
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization
por: Rodà, Francesca, et al.
Publicado: (2023)

Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles
por: Ottonelli, Ilaria, et al.
Publicado: (2022)

Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments
por: Duskey, Jason Thomas, et al.
Publicado: (2022)

Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function
por: Duskey, Jason Thomas, et al.
Publicado: (2020)

Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
por: Pederzoli, Francesca, et al.
Publicado: (2019)

Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles
por: Rigon, Laura, et al.
Publicado: (2019)

Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications
por: Duskey, Jason Thomas, et al.
Publicado: (2020)

“Combo” Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury
por: Moretti, Marzia, et al.
Publicado: (2023)

Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
por: Rinaldi, Arianna, et al.
Publicado: (2022)

Tween(®) Preserves Enzyme Activity and Stability in PLGA Nanoparticles
por: Duskey, Jason Thomas, et al.
Publicado: (2021)

Microfluidic Technology for the Production of Hybrid Nanomedicines
por: Ottonelli, Ilaria, et al.
Publicado: (2021)

PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study
por: Hoyos-Ceballos, Gina P., et al.
Publicado: (2020)

Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s disease
por: Birolini, Giulia, et al.
Publicado: (2023)

Fat pharms.
por: Ma, M
Publicado: (1996)

The technology of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

The Evolution of PharmVar
por: Gaedigk, Andrea, et al.
Publicado: (2018)

Legal problems of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles
por: Vilella, Antonietta, et al.
Publicado: (2015)

ECOLOGY AND WILDLIFE: Pharmed Fish
por: Betts, Kellyn S.
Publicado: (2009)

PharmGED: Pharmacogenetic Effect Database
por: Zheng, C. J., et al.
Publicado: (2007)

Cell Engineering and Molecular Pharming for Biopharmaceuticals
por: Abdullah, M.A, et al.
Publicado: (2008)

Introduction of APCs in J. Young Pharm.
por: Mueen, Ahmed KK
Publicado: (2012)

My Vision: J Young Pharm
por: Parasuraman, S
Publicado: (2012)

Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment
por: Oddone, Natalia, et al.
Publicado: (2020)

Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders
por: Salvalaio, Marika, et al.
Publicado: (2016)

Pharm D: A new concept in India
por: Deshpande, Prasanna R., et al.
Publicado: (2012)

Pharmacogenomics Clinical Annotation Tool (PharmCAT)
por: Sangkuhl, Katrin, et al.
Publicado: (2019)

Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study
por: Leendertse, Anne J, et al.
Publicado: (2011)

Isolation methods for particle protein corona complexes from protein-rich matrices
por: Böhmert, Linda, et al.
Publicado: (2020)

AlzPharm: integration of neurodegeneration data using RDF
por: Lam, Hugo YK, et al.
Publicado: (2007)

Using ODIN for a PharmGKB revalidation experiment
por: Rinaldi, Fabio, et al.
Publicado: (2012)

J Young Pharm. 2011: What are we aiming at?
por: Mueen, Ahmed KK
Publicado: (2011)

The National Gene Vector Biorepository's Pharm/Tox Database
por: Cornetta, Kenneth, et al.
Publicado: (2009)

PharmDock: a pharmacophore-based docking program
por: Hu, Bingjie, et al.
Publicado: (2014)

PharmGKB Drug Data Normalization with NDF-RT
por: Zhu, Qian, et al.
Publicado: (2013)

PharmGKB: A worldwide resource for pharmacogenomic information
por: Barbarino, Julia M., et al.
Publicado: (2018)

PharmCAT: A Pharmacogenomics Clinical Annotation Tool
por: Klein, Teri E., et al.
Publicado: (2017)

PharmML in Action: an Interoperable Language for Modeling and Simulation
por: Bizzotto, R, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_43ghheu6s45omba8imj9a3bsvs